Literature DB >> 32865379

Revisiting Rate versus Rhythm Control in Atrial Fibrillation - Timing Matters.

T Jared Bunch1, Benjamin A Steinberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32865379     DOI： 10.1056/NEJMe2027180

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Acute rate control in atrial fibrillation: an urgent need for the clinician.

Authors:  Gheorghe-Andrei Dan; Anca R Dan; Andreea Ivanescu; Adrian C Buzea
Journal:  Eur Heart J Suppl       Date:  2022-06-13       Impact factor: 1.624

Review 2.  Rate control strategies for atrial fibrillation.

Authors:  Muath Alobaida; Abdullah Alrumayh
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

3.  Highlights from the European society of cardiology congress 2020.

Authors:  Pooneh Nabavizadeh; Dylan L Steen
Journal:  J Thromb Thrombolysis       Date:  2021-01-06       Impact factor: 2.300

4.  Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablation.

Authors:  Derek S Chew; Kelley A Jones; Zak Loring; Eric Black-Maier; Peter A Noseworthy; Derek V Exner; Douglas L Packer; Jennifer Grant; Daniel B Mark; Jonathan P Piccini
Journal:  Heart Rhythm O2       Date:  2021-11-19

5.  Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry.

Authors:  Giuseppe Boriani; Gregory Y H Lip; Marco Proietti; Marco Vitolo; Stephanie L Harrison; Deirdre A Lane; Laurent Fauchier; Francisco Marin; Michael Nabauer; Tatjana S Potpara; Gheorghe-Andrei Dan
Journal:  Clin Res Cardiol       Date:  2021-08-27       Impact factor: 5.460

Review 6.  Catheter ablation for atrial fibrillation: impact on mortality, morbidity, quality of life, and implications for the future.

Authors:  Patrick Dilk; Rolf Wachter; Gerhard Hindricks
Journal:  Herz       Date:  2022-03-08       Impact factor: 1.443

7.  Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial.

Authors:  Andreas Metzner; Anna Suling; Axel Brandes; Günter Breithardt; A John Camm; Harry J G M Crijns; Lars Eckardt; Arif Elvan; Andreas Goette; Laurent M Haegeli; Hein Heidbuchel; Josef Kautzner; Karl-Heinz Kuck; Luis Mont; G Andre Ng; Lukasz Szumowski; Sakis Themistoclakis; Isabelle C van Gelder; Panos Vardas; Karl Wegscheider; Stephan Willems; Paulus Kirchhof
Journal:  Europace       Date:  2022-04-05       Impact factor: 5.214
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.